Advertisement

Head and Neck Pathology

, Volume 2, Issue 4, pp 305–308 | Cite as

Parathyroid Adenoma

  • Jacqueline A. WienekeEmail author
  • Alice Smith
Sine qua none Radiology-Pathology

Introduction

Parathyroid adenoma is part of a spectrum of parathyroid proliferative disorder that includes parathyroid hyperplasia, parathyroid adenoma, and parathyroid carcinoma. Patients typically present with evidence of primary hyperparathyroidism with elevated serum calcium levels and elevated serum parathyroid hormone levels. Hyperparathyroidism is divided into primary, secondary, and tertiary hyperparathyroidism. Most parathyroid hyperplasia is the result of secondary hyperparathyroidism due to renal disease. Tertiary hyperparathyroidism is the autonomous secretion of parathyroid hormone in the setting of long-standing renal disease resulting in hypercalcemia. Eighty to 85 percent of primary hyperparathyroidism is caused by parathyroid adenoma followed by primary parathyroid hyperplasia (15%) and parathyroid carcinoma (5%).

Patients with primary hyperparathyroidism may present with clinical evidence of elevated serum calcium levels which include non-specific symptoms such as...

Keywords

Primary Hyperparathyroidism Parathyroid Adenoma Parathyroid Carcinoma Parathyroid Neoplasm Parathyroid Hyperplasia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Open Access

This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Bibliography

  1. Smith JR, Oates ME. Radiolonuclide imaging of parathyroid glands: patterns, pearls, and pitfalls. Radiographics. 2004;24:1101–15. doi: 10.1148/rg.244035718.PubMedCrossRefGoogle Scholar
  2. Clark PB, Perrier ND, Morton KA. Detection of an intrathymic parathyroid adenoma using single-photon emission CT 99mTc sestamibi scintigraphy and CT. AJR Am J Roentgenol. 2005;184(Suppl 3):S16–8.PubMedGoogle Scholar
  3. Johnson NA, Tublin ME, Ogilvie JB. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. AJR Am J Roentgenol. 2007;188:1706–15. doi: 10.2214/AJR.06.0938.PubMedCrossRefGoogle Scholar
  4. Thompson LDR. Benign neoplasms of the parathyroid gland. In: Thompson LDR, editor. Endocrine pathology, foundations in diagnostic pathology. Philadelphia: Churchill Livingstone/Elsevier; 2006. p. 157–164.Google Scholar
  5. Sharma J, Milas M, Berber E, et al. Value of intraoperative parathyroid hormone monitoring. Ann Surg Oncol. 2008;15(2):493–8. doi: 10.1245/s10434-007-9683-2.PubMedCrossRefGoogle Scholar
  6. Stojadinovic A, Hoos A, Nissan A, et al. Parathyroid neoplasms: clinical, histopathological and tissue microarray-based molecular analysis. Hum Pathol. 2003;34(1):54–64. doi: 10.1053/hupa.2003.55.PubMedCrossRefGoogle Scholar
  7. Erickson LA, Jin L, Wollan P, et al. Parathyroid hyperplasia, adenomas and carcinomas. Differential expression of p27 protein. Am J Surg Pathol. 1999;23(3):288–95. doi: 10.1097/00000478-199903000-00007.PubMedCrossRefGoogle Scholar
  8. Gill AJ, Clarkson A, Gimm O, et al. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias. Am J Surg Pathol. 2006;30(9):1140–9. doi: 10.1097/01.pas.0000209827.39477.4f.PubMedGoogle Scholar
  9. Mittendorf EA, McHenry CR. Parathyroid carcinoma. J Surg Oncol. 2005;89(3):136–42. doi: 10.1002/jso.20182.PubMedCrossRefGoogle Scholar
  10. Tan MH, Morrison C, Wang P, et al. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clin Cancer Res. 2004;10(19):6629–37. doi: 10.1158/1078-0432.CCR-04-0493.PubMedCrossRefGoogle Scholar

Copyright information

© The Author(s) 2008

Authors and Affiliations

  1. 1.Department of Otorhinolaryngic-Head and Neck and Endocrine PathologyArmed Forces Institute of PathologyWashingtonUSA

Personalised recommendations